Tactical Edge

Security and trust center evidence

Real-time asset tracking, inventory management & fleet monitoring for federal agencies and commercial

tvasolution.com DevOps and observabilityLast verified 1 Nov 2026

Tactical Edge has 1 registry-verified row in the CertReports index, last verified 1 Nov 2026. The strongest row is FedRAMP: FedRAMP Authorized. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

As of 1 Nov 2026, CertReports holds 1 registry-verified row for Tactical Edge, drawn from FedRAMP Marketplace. Tactical Edge is listed in the FedRAMP Marketplace for FedRAMP (FedRAMP Authorized), dated 9 Apr 2025, assessed by Ignyte Platform Inc.. No public evidence was found for SOC 2, ISO/IEC 27001, HIPAA and GDPR as of 1 Nov 2026; that is a gap in the public record, not a finding of non-coverage, and the vendor can supply it under NDA.

FedRAMP: FedRAMP Authorized, verified as of 1 Nov 2026

Facts only, each dated; nothing here is inferred, scored or advised.

Among devops and observability vendors

1verified rows

Category median 1, across 193 indexed devops and observability vendors. Tactical Edge has more verified rows than 44 percent of them.

Compare with similar vendors

Pick your own comparison

Compliance grid

FedRAMPVerified
FedRAMP Authorized
as of 1 Nov 2026
46 sources · Ignyte Platform Inc.

No public evidence yet for HIPAA, SOC 2, GDPR, PCI DSS, ISO 27001, CSA STAR, Cyber Essentials, ISO 27701, ISO 42001. This does not mean the vendor lacks them; it means nothing public was found at the last check.

Legal artefacts

No DPA, BAA or subprocessor list has been captured from a public page yet. Registry rows above do not depend on this.

Subprocessors

No subprocessor list captured yet.

Change history

18 Sep 2026First indexed by CertReports1 evidence row across 1 framework entered the index.

Similar vendors with evidence

Related by product tags and the DevOps and observability category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.